Bladder Neoplasm
|
281
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2008 |
2008 |
Carcinoma of bladder
|
309
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2008 |
2008 |
Laryngeal Diseases
|
7
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2008 |
2008 |
Malignant neoplasm of urinary bladder
|
316
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2008 |
2008 |
Nasopharyngeal carcinoma
|
320
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
1 |
2010 |
2010 |
Differentiated Thyroid Gland Carcinoma
|
80
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
|
1 |
2011 |
2011 |
Metastasis from malignant tumor of prostate
|
18
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2011 |
2011 |
Metastatic Prostate Carcinoma
|
24
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2011 |
2011 |
Primary differentiated carcinoma of thyroid gland
|
41
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
|
1 |
2011 |
2011 |
Alcohol or Other Drugs use
|
21
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Diabetes Mellitus, Non-Insulin-Dependent
|
2672
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Intestinal Neoplasms
|
2
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Colon Carcinoma
|
275
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.070 |
1.000 |
7 |
2008 |
2013 |
Adult Liver Carcinoma
|
72
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.020 |
1.000 |
2 |
2008 |
2014 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
73
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.020 |
1.000 |
2 |
2008 |
2014 |
Malignant neoplasm of liver
|
88
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.020 |
1.000 |
2 |
2008 |
2014 |
polyps
|
18
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Papillary thyroid carcinoma
|
204
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.020 |
|
2 |
2012 |
2015 |
Breast Carcinoma
|
2793
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
0.750 |
4 |
2008 |
2016 |
Malignant neoplasm of breast
|
3417
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
0.750 |
4 |
2008 |
2016 |
Endometrial Carcinoma
|
326
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Secondary malignant neoplasm of lymph node
|
188
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Malignant neoplasm of prostate
|
1082
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.800 |
0.857 |
28 |
2007 |
2017 |
Malignant neoplasm of thyroid
|
103
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.050 |
1.000 |
5 |
2012 |
2017 |
Thyroid carcinoma
|
145
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.050 |
1.000 |
5 |
2012 |
2017 |